Tech firms dominated Monday's worst performers, with Recursion Pharmaceuticals dropping by 4.34%. Despite a recent surge, the company faced profit-taking amid a quiet market. RXRX utilizes AI for drug discovery, with potential for lower costs and quicker evaluations.